Cabergoline treatment in human primary non-functioning pituitary adenomas
Federica Begalli, Márta Korbonits(Queen Mary University of London), Joaquín Botta, Tatsuya Komagata, Oniz Suleyman, Peter J. McCormick(Queen Mary University of London), Joan Grieve, David Collier(University of London), Koji Shinozaki, Hani J. Marcus(Wellcome / EPSRC Centre for Interventional and Surgical Sciences), Kesson Magid, Angelos G. Kolias(University of Cambridge), Ramesh Nair, Thomas Rice(University of Exeter), Danyal Z. Khan(Wellcome / EPSRC Centre for Interventional and Surgical Sciences), Nigel Mendoza, Neil Dorward
Cited by 0
Related Papers
Traumatic brain injury: progress and challenges in prevention, clinical care, and research
|The Lancet Neurology|2022|1.5k
Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial
|The Lancet|2017|1k
Use of Drains versus No Drains after Burr-Hole Evacuation of Chronic Subdural Haematoma: A Randomised Controlled Trial
|The Lancet|2009|727
Cannabinoids and Ghrelin Have Both Central and Peripheral Metabolic and Cardiac Effects via AMP-activated Protein Kinase
|Journal of Biological Chemistry|2005|469